 | • レポートコード：QYR2104Z3695 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、メニエール病のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医療薬、注射、陽圧療法、手術）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・メニエール病の市場動向 ・企業の競争状況、市場シェア ・メニエール病の種類別市場規模（医療薬、注射、陽圧療法、手術） ・メニエール病の用途別市場規模（病院、専門クリニック、その他） ・メニエール病の北米市場規模2016-2027（アメリカ、カナダ） ・メニエール病のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・メニエール病のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メニエール病の中南米市場規模2016-2027（メキシコ、ブラジル） ・メニエール病の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Auris Medical、Jubilant Cadista、Otonomy、Prestige Brands Holdings、Sound Pharmaceuticals、The Ear Company、WellSpring Pharmaceutical） ・結論 |
Ménière’s disease (MD) is a disorder of the inner ear that is characterized by episodes of feeling like the world is spinning (vertigo), ringing in the ears (tinnitus), hearing loss, and a fullness in the ear. Typically only one ear is affected, at least initially; however, over time both ears may become involved. Episodes generally last from 20 minutes to a few hours. The time between episodes varies. The hearing loss and ringing in the ears may become constant over time.
There is no cure for Ménière’s disease but medications, diet, physical therapy and counseling, and some surgical approaches can be used to manage it.
Market Analysis and Insights: Global Meniere’s Disease Market
The global Meniere’s Disease market size is projected to reach US$ 5876.9 million by 2026, from US$ 4747 million in 2019, at a CAGR of 3.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meniere’s Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meniere’s Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meniere’s Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meniere’s Disease market.
Global Meniere’s Disease Scope and Market Size
Meniere’s Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meniere’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Treatment and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Treatment
Drug
Injections
Positive Pressure Therapy
Surgery
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Auris Medical
Jubilant Cadista
Otonomy
Prestige Brands Holdings
Sound Pharmaceuticals
The Ear Company
WellSpring Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meniere’s Disease Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
1.2.2 Drug
1.2.3 Injections
1.2.4 Positive Pressure Therapy
1.2.5 Surgery
1.3 Market by Application
1.3.1 Global Meniere’s Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Meniere’s Disease Market Perspective (2016-2027)
2.2 Meniere’s Disease Growth Trends by Regions
2.2.1 Meniere’s Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Meniere’s Disease Historic Market Share by Regions (2016-2021)
2.2.3 Meniere’s Disease Forecasted Market Size by Regions (2022-2027)
2.3 Meniere’s Disease Industry Dynamic
2.3.1 Meniere’s Disease Market Trends
2.3.2 Meniere’s Disease Market Drivers
2.3.3 Meniere’s Disease Market Challenges
2.3.4 Meniere’s Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meniere’s Disease Players by Revenue
3.1.1 Global Top Meniere’s Disease Players by Revenue (2016-2021)
3.1.2 Global Meniere’s Disease Revenue Market Share by Players (2016-2021)
3.2 Global Meniere’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Meniere’s Disease Revenue
3.4 Global Meniere’s Disease Market Concentration Ratio
3.4.1 Global Meniere’s Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meniere’s Disease Revenue in 2020
3.5 Meniere’s Disease Key Players Head office and Area Served
3.6 Key Players Meniere’s Disease Product Solution and Service
3.7 Date of Enter into Meniere’s Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meniere’s Disease Breakdown Data by Treatment
4.1 Global Meniere’s Disease Historic Market Size by Treatment (2016-2021)
4.2 Global Meniere’s Disease Forecasted Market Size by Treatment (2022-2027)
5 Meniere’s Disease Breakdown Data by Application
5.1 Global Meniere’s Disease Historic Market Size by Application (2016-2021)
5.2 Global Meniere’s Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Meniere’s Disease Market Size (2016-2027)
6.2 North America Meniere’s Disease Market Size by Treatment
6.2.1 North America Meniere’s Disease Market Size by Treatment (2016-2021)
6.2.2 North America Meniere’s Disease Market Size by Treatment (2022-2027)
6.2.3 North America Meniere’s Disease Market Size by Treatment (2016-2027)
6.3 North America Meniere’s Disease Market Size by Application
6.3.1 North America Meniere’s Disease Market Size by Application (2016-2021)
6.3.2 North America Meniere’s Disease Market Size by Application (2022-2027)
6.3.3 North America Meniere’s Disease Market Size by Application (2016-2027)
6.4 North America Meniere’s Disease Market Size by Country
6.4.1 North America Meniere’s Disease Market Size by Country (2016-2021)
6.4.2 North America Meniere’s Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Meniere’s Disease Market Size (2016-2027)
7.2 Europe Meniere’s Disease Market Size by Treatment
7.2.1 Europe Meniere’s Disease Market Size by Treatment (2016-2021)
7.2.2 Europe Meniere’s Disease Market Size by Treatment (2022-2027)
7.2.3 Europe Meniere’s Disease Market Size by Treatment (2016-2027)
7.3 Europe Meniere’s Disease Market Size by Application
7.3.1 Europe Meniere’s Disease Market Size by Application (2016-2021)
7.3.2 Europe Meniere’s Disease Market Size by Application (2022-2027)
7.3.3 Europe Meniere’s Disease Market Size by Application (2016-2027)
7.4 Europe Meniere’s Disease Market Size by Country
7.4.1 Europe Meniere’s Disease Market Size by Country (2016-2021)
7.4.2 Europe Meniere’s Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Meniere’s Disease Market Size (2016-2027)
8.2 Asia-Pacific Meniere’s Disease Market Size by Treatment
8.2.1 Asia-Pacific Meniere’s Disease Market Size by Treatment (2016-2021)
8.2.2 Asia-Pacific Meniere’s Disease Market Size by Treatment (2022-2027)
8.2.3 Asia-Pacific Meniere’s Disease Market Size by Treatment (2016-2027)
8.3 Asia-Pacific Meniere’s Disease Market Size by Application
8.3.1 Asia-Pacific Meniere’s Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Meniere’s Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Meniere’s Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Meniere’s Disease Market Size by Region
8.4.1 Asia-Pacific Meniere’s Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Meniere’s Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Meniere’s Disease Market Size (2016-2027)
9.2 Latin America Meniere’s Disease Market Size by Treatment
9.2.1 Latin America Meniere’s Disease Market Size by Treatment (2016-2021)
9.2.2 Latin America Meniere’s Disease Market Size by Treatment (2022-2027)
9.2.3 Latin America Meniere’s Disease Market Size by Treatment (2016-2027)
9.3 Latin America Meniere’s Disease Market Size by Application
9.3.1 Latin America Meniere’s Disease Market Size by Application (2016-2021)
9.3.2 Latin America Meniere’s Disease Market Size by Application (2022-2027)
9.3.3 Latin America Meniere’s Disease Market Size by Application (2016-2027)
9.4 Latin America Meniere’s Disease Market Size by Country
9.4.1 Latin America Meniere’s Disease Market Size by Country (2016-2021)
9.4.2 Latin America Meniere’s Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meniere’s Disease Market Size (2016-2027)
10.2 Middle East & Africa Meniere’s Disease Market Size by Treatment
10.2.1 Middle East & Africa Meniere’s Disease Market Size by Treatment (2016-2021)
10.2.2 Middle East & Africa Meniere’s Disease Market Size by Treatment (2022-2027)
10.2.3 Middle East & Africa Meniere’s Disease Market Size by Treatment (2016-2027)
10.3 Middle East & Africa Meniere’s Disease Market Size by Application
10.3.1 Middle East & Africa Meniere’s Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Meniere’s Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Meniere’s Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Meniere’s Disease Market Size by Country
10.4.1 Middle East & Africa Meniere’s Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Meniere’s Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Auris Medical
11.1.1 Auris Medical Company Details
11.1.2 Auris Medical Business Overview
11.1.3 Auris Medical Meniere’s Disease Introduction
11.1.4 Auris Medical Revenue in Meniere’s Disease Business (2016-2021)
11.1.5 Auris Medical Recent Development
11.2 Jubilant Cadista
11.2.1 Jubilant Cadista Company Details
11.2.2 Jubilant Cadista Business Overview
11.2.3 Jubilant Cadista Meniere’s Disease Introduction
11.2.4 Jubilant Cadista Revenue in Meniere’s Disease Business (2016-2021)
11.2.5 Jubilant Cadista Recent Development
11.3 Otonomy
11.3.1 Otonomy Company Details
11.3.2 Otonomy Business Overview
11.3.3 Otonomy Meniere’s Disease Introduction
11.3.4 Otonomy Revenue in Meniere’s Disease Business (2016-2021)
11.3.5 Otonomy Recent Development
11.4 Prestige Brands Holdings
11.4.1 Prestige Brands Holdings Company Details
11.4.2 Prestige Brands Holdings Business Overview
11.4.3 Prestige Brands Holdings Meniere’s Disease Introduction
11.4.4 Prestige Brands Holdings Revenue in Meniere’s Disease Business (2016-2021)
11.4.5 Prestige Brands Holdings Recent Development
11.5 Sound Pharmaceuticals
11.5.1 Sound Pharmaceuticals Company Details
11.5.2 Sound Pharmaceuticals Business Overview
11.5.3 Sound Pharmaceuticals Meniere’s Disease Introduction
11.5.4 Sound Pharmaceuticals Revenue in Meniere’s Disease Business (2016-2021)
11.5.5 Sound Pharmaceuticals Recent Development
11.6 The Ear Company
11.6.1 The Ear Company Company Details
11.6.2 The Ear Company Business Overview
11.6.3 The Ear Company Meniere’s Disease Introduction
11.6.4 The Ear Company Revenue in Meniere’s Disease Business (2016-2021)
11.6.5 The Ear Company Recent Development
11.7 WellSpring Pharmaceutical
11.7.1 WellSpring Pharmaceutical Company Details
11.7.2 WellSpring Pharmaceutical Business Overview
11.7.3 WellSpring Pharmaceutical Meniere’s Disease Introduction
11.7.4 WellSpring Pharmaceutical Revenue in Meniere’s Disease Business (2016-2021)
11.7.5 WellSpring Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Meniere’s Disease Market Size Growth Rate by Treatment (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug
Table 3. Key Players of Injections
Table 4. Key Players of Positive Pressure Therapy
Table 5. Key Players of Surgery
Table 6. Global Meniere’s Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Meniere’s Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Meniere’s Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Meniere’s Disease Market Share by Regions (2016-2021)
Table 10. Global Meniere’s Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Meniere’s Disease Market Share by Regions (2022-2027)
Table 12. Meniere’s Disease Market Trends
Table 13. Meniere’s Disease Market Drivers
Table 14. Meniere’s Disease Market Challenges
Table 15. Meniere’s Disease Market Restraints
Table 16. Global Meniere’s Disease Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Meniere’s Disease Market Share by Players (2016-2021)
Table 18. Global Top Meniere’s Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere’s Disease as of 2020)
Table 19. Ranking of Global Top Meniere’s Disease Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Meniere’s Disease Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Meniere’s Disease Product Solution and Service
Table 23. Date of Enter into Meniere’s Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Meniere’s Disease Market Size by Treatment (2016-2021) (US$ Million)
Table 26. Global Meniere’s Disease Revenue Market Share by Treatment (2016-2021)
Table 27. Global Meniere’s Disease Forecasted Market Size by Treatment (2022-2027) (US$ Million)
Table 28. Global Meniere’s Disease Revenue Market Share by Treatment (2022-2027) & (US$ Million)
Table 29. Global Meniere’s Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Meniere’s Disease Revenue Market Share by Application (2016-2021)
Table 31. Global Meniere’s Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Meniere’s Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Meniere’s Disease Market Size by Treatment (2016-2021) (US$ Million)
Table 34. North America Meniere’s Disease Market Size by Treatment (2022-2027) & (US$ Million)
Table 35. North America Meniere’s Disease Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Meniere’s Disease Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Meniere’s Disease Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Meniere’s Disease Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Meniere’s Disease Market Size by Treatment (2016-2021) (US$ Million)
Table 40. Europe Meniere’s Disease Market Size by Treatment (2022-2027) & (US$ Million)
Table 41. Europe Meniere’s Disease Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Meniere’s Disease Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Meniere’s Disease Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Meniere’s Disease Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Meniere’s Disease Market Size by Treatment (2016-2021) (US$ Million)
Table 46. Asia-Pacific Meniere’s Disease Market Size by Treatment (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Meniere’s Disease Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Meniere’s Disease Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Meniere’s Disease Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Meniere’s Disease Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Meniere’s Disease Market Size by Treatment (2016-2021) (US$ Million)
Table 52. Latin America Meniere’s Disease Market Size by Treatment (2022-2027) & (US$ Million)
Table 53. Latin America Meniere’s Disease Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Meniere’s Disease Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Meniere’s Disease Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Meniere’s Disease Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Meniere’s Disease Market Size by Treatment (2016-2021) (US$ Million)
Table 58. Middle East & Africa Meniere’s Disease Market Size by Treatment (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Meniere’s Disease Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Meniere’s Disease Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Meniere’s Disease Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Meniere’s Disease Market Size by Country (2022-2027) & (US$ Million)
Table 63. Auris Medical Company Details
Table 64. Auris Medical Business Overview
Table 65. Auris Medical Meniere’s Disease Product
Table 66. Auris Medical Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 67. Auris Medical Recent Development
Table 68. Jubilant Cadista Company Details
Table 69. Jubilant Cadista Business Overview
Table 70. Jubilant Cadista Meniere’s Disease Product
Table 71. Jubilant Cadista Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 72. Jubilant Cadista Recent Development
Table 73. Otonomy Company Details
Table 74. Otonomy Business Overview
Table 75. Otonomy Meniere’s Disease Product
Table 76. Otonomy Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 77. Otonomy Recent Development
Table 78. Prestige Brands Holdings Company Details
Table 79. Prestige Brands Holdings Business Overview
Table 80. Prestige Brands Holdings Meniere’s Disease Product
Table 81. Prestige Brands Holdings Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 82. Prestige Brands Holdings Recent Development
Table 83. Sound Pharmaceuticals Company Details
Table 84. Sound Pharmaceuticals Business Overview
Table 85. Sound Pharmaceuticals Meniere’s Disease Product
Table 86. Sound Pharmaceuticals Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 87. Sound Pharmaceuticals Recent Development
Table 88. The Ear Company Company Details
Table 89. The Ear Company Business Overview
Table 90. The Ear Company Meniere’s Disease Product
Table 91. The Ear Company Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 92. The Ear Company Recent Development
Table 93. WellSpring Pharmaceutical Company Details
Table 94. WellSpring Pharmaceutical Business Overview
Table 95. WellSpring Pharmaceutical Meniere’s Disease Product
Table 96. WellSpring Pharmaceutical Revenue in Meniere’s Disease Business (2016-2021) & (US$ Million)
Table 97. WellSpring Pharmaceutical Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meniere’s Disease Market Share by Treatment: 2020 VS 2027
Figure 2. Drug Features
Figure 3. Injections Features
Figure 4. Positive Pressure Therapy Features
Figure 5. Surgery Features
Figure 6. Global Meniere’s Disease Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Meniere’s Disease Report Years Considered
Figure 11. Global Meniere’s Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Meniere’s Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Meniere’s Disease Market Share by Regions: 2020 VS 2027
Figure 14. Global Meniere’s Disease Market Share by Regions (2022-2027)
Figure 15. Global Meniere’s Disease Market Share by Players in 2020
Figure 16. Global Top Meniere’s Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meniere’s Disease as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Meniere’s Disease Revenue in 2020
Figure 18. Global Meniere’s Disease Revenue Market Share by Treatment (2016-2021)
Figure 19. Global Meniere’s Disease Revenue Market Share by Treatment (2022-2027)
Figure 20. North America Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Meniere’s Disease Market Share by Treatment (2016-2027)
Figure 22. North America Meniere’s Disease Market Share by Application (2016-2027)
Figure 23. North America Meniere’s Disease Market Share by Country (2016-2027)
Figure 24. United States Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Meniere’s Disease Market Share by Treatment (2016-2027)
Figure 28. Europe Meniere’s Disease Market Share by Application (2016-2027)
Figure 29. Europe Meniere’s Disease Market Share by Country (2016-2027)
Figure 30. Germany Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Meniere’s Disease Market Share by Treatment (2016-2027)
Figure 38. Asia-Pacific Meniere’s Disease Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Meniere’s Disease Market Share by Region (2016-2027)
Figure 40. China Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Meniere’s Disease Market Share by Treatment (2016-2027)
Figure 48. Latin America Meniere’s Disease Market Share by Application (2016-2027)
Figure 49. Latin America Meniere’s Disease Market Share by Country (2016-2027)
Figure 50. Mexico Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Meniere’s Disease Market Share by Treatment (2016-2027)
Figure 54. Middle East & Africa Meniere’s Disease Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Meniere’s Disease Market Share by Country (2016-2027)
Figure 56. Turkey Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Meniere’s Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Auris Medical Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 60. Jubilant Cadista Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 61. Otonomy Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 62. Prestige Brands Holdings Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 63. Sound Pharmaceuticals Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 64. The Ear Company Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 65. WellSpring Pharmaceutical Revenue Growth Rate in Meniere’s Disease Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のメニエール病治療市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…- 世界のメニエール病治療薬市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
- 世界のメニエール病治療薬市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
- 世界のクッシング病治療市場規模・現状・予測（2021年-2027年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- 世界のクラッベ病治療市場規模・現状・予測（2021年-2027年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…